PaxMedica (PXMD) Stock Rises After Positive Clinical Results
PaxMedica, Inc. (NASDAQ: PXMD) exhibited a notable upswing of 47.54% in its stock price, ultimately settling at $4.50 during the previous trading session. This substantial surge in PaxMedica’s stock value can be attributed to a publication announcement by the biopharmaceutical company. On Tuesday, PaxMedica (PXMD) officially disclosed their groundbreaking research findings in the prestigious Annals […]